Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global HIV/AIDS Testing Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Kits and Reagents
  • 1.4.3 Instruments
  • 1.4.4 Others
• 1.5 Market by Application
  • 1.5.1 Global HIV/AIDS Testing Market Share by Application (2014-2025)
  • 1.5.2 Hospitals
  • 1.5.3 Private Diagnostics Laboratories
  • 1.5.4 Academic and Research Institutes
  • 1.5.5 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 HIV/AIDS Testing Market Size
• 2.2 HIV/AIDS Testing Growth Trends by Regions
  • 2.2.1 HIV/AIDS Testing Market Size by Regions (2014-2025)
  • 2.2.2 HIV/AIDS Testing Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Opportunities

3 Market Share by Key Players

• 3.1 HIV/AIDS Testing Market Size by Manufacturers
  • 3.1.1 Global HIV/AIDS Testing Revenue by Manufacturers (2014-2019)
  • 3.1.2 Global HIV/AIDS Testing Revenue Market Share by Manufacturers (2014-2019)
  • 3.1.3 Global HIV/AIDS Testing Market Concentration Ratio (CR5 and HHI)
• 3.2 HIV/AIDS Testing Key Players Head office and Area Served
• 3.3 Key Players HIV/AIDS Testing Product/Solution/Service
• 3.4 Date of Enter into HIV/AIDS Testing Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global HIV/AIDS Testing Market Size by Type (2014-2019)
• 4.2 Global HIV/AIDS Testing Market Size by Application (2014-2019)

5 United States

• 5.1 United States HIV/AIDS Testing Market Size (2014-2019)
• 5.2 HIV/AIDS Testing Key Players in United States
• 5.3 United States HIV/AIDS Testing Market Size by Type
• 5.4 United States HIV/AIDS Testing Market Size by Application

6 Europe

• 6.1 Europe HIV/AIDS Testing Market Size (2014-2019)
• 6.2 HIV/AIDS Testing Key Players in Europe
• 6.3 Europe HIV/AIDS Testing Market Size by Type
• 6.4 Europe HIV/AIDS Testing Market Size by Application

7 China

• 7.1 China HIV/AIDS Testing Market Size (2014-2019)
• 7.2 HIV/AIDS Testing Key Players in China
• 7.3 China HIV/AIDS Testing Market Size by Type
• 7.4 China HIV/AIDS Testing Market Size by Application

8 Japan

• 8.1 Japan HIV/AIDS Testing Market Size (2014-2019)
• 8.2 HIV/AIDS Testing Key Players in Japan
• 8.3 Japan HIV/AIDS Testing Market Size by Type
• 8.4 Japan HIV/AIDS Testing Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia HIV/AIDS Testing Market Size (2014-2019)
• 9.2 HIV/AIDS Testing Key Players in Southeast Asia
• 9.3 Southeast Asia HIV/AIDS Testing Market Size by Type
• 9.4 Southeast Asia HIV/AIDS Testing Market Size by Application

10 India

• 10.1 India HIV/AIDS Testing Market Size (2014-2019)
• 10.2 HIV/AIDS Testing Key Players in India
• 10.3 India HIV/AIDS Testing Market Size by Type
• 10.4 India HIV/AIDS Testing Market Size by Application

11 Central & South America

• 11.1 Central & South America HIV/AIDS Testing Market Size (2014-2019)
• 11.2 HIV/AIDS Testing Key Players in Central & South America
• 11.3 Central & South America HIV/AIDS Testing Market Size by Type
• 11.4 Central & South America HIV/AIDS Testing Market Size by Application

12 International Players Profiles

• 12.1 Abbott
  • 12.1.1 Abbott Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 HIV/AIDS Testing Introduction
  • 12.1.4 Abbott Revenue in HIV/AIDS Testing Business (2014-2019)
  • 12.1.5 Abbott Recent Development
• 12.2 Affymetrix
  • 12.2.1 Affymetrix Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 HIV/AIDS Testing Introduction
  • 12.2.4 Affymetrix Revenue in HIV/AIDS Testing Business (2014-2019)
  • 12.2.5 Affymetrix Recent Development
• 12.3 Beckman Coulter/Danaher
  • 12.3.1 Beckman Coulter/Danaher Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 HIV/AIDS Testing Introduction
  • 12.3.4 Beckman Coulter/Danaher Revenue in HIV/AIDS Testing Business (2014-2019)
  • 12.3.5 Beckman Coulter/Danaher Recent Development
• 12.4 Becton Dickinson
  • 12.4.1 Becton Dickinson Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 HIV/AIDS Testing Introduction
  • 12.4.4 Becton Dickinson Revenue in HIV/AIDS Testing Business (2014-2019)
  • 12.4.5 Becton Dickinson Recent Development
• 12.5 bioMerieux
  • 12.5.1 bioMerieux Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 HIV/AIDS Testing Introduction
  • 12.5.4 bioMerieux Revenue in HIV/AIDS Testing Business (2014-2019)
  • 12.5.5 bioMerieux Recent Development
• 12.6 Bio-Rad
  • 12.6.1 Bio-Rad Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 HIV/AIDS Testing Introduction
  • 12.6.4 Bio-Rad Revenue in HIV/AIDS Testing Business (2014-2019)
  • 12.6.5 Bio-Rad Recent Development
• 12.7 Cepheid
  • 12.7.1 Cepheid Company Details
  • 12.7.2 Company Description and Business Overview
  • 12.7.3 HIV/AIDS Testing Introduction
  • 12.7.4 Cepheid Revenue in HIV/AIDS Testing Business (2014-2019)
  • 12.7.5 Cepheid Recent Development
• 12.8 Diamedix
  • 12.8.1 Diamedix Company Details
  • 12.8.2 Company Description and Business Overview
  • 12.8.3 HIV/AIDS Testing Introduction
  • 12.8.4 Diamedix Revenue in HIV/AIDS Testing Business (2014-2019)
  • 12.8.5 Diamedix Recent Development
• 12.9 DiaSorin
  • 12.9.1 DiaSorin Company Details
  • 12.9.2 Company Description and Business Overview
  • 12.9.3 HIV/AIDS Testing Introduction
  • 12.9.4 DiaSorin Revenue in HIV/AIDS Testing Business (2014-2019)
  • 12.9.5 DiaSorin Recent Development
• 12.10 Eiken Chemical
  • 12.10.1 Eiken Chemical Company Details
  • 12.10.2 Company Description and Business Overview
  • 12.10.3 HIV/AIDS Testing Introduction
  • 12.10.4 Eiken Chemical Revenue in HIV/AIDS Testing Business (2014-2019)
  • 12.10.5 Eiken Chemical Recent Development
• 12.11 Elitech Group
• 12.12 Enzo Biochem
• 12.13 Fujirebio
• 12.14 Lonza
• 12.15 Roche
• 12.16 Scienion
• 12.17 Sequenom
• 12.18 SeraCare
• 12.19 Siemens
• 12.20 Takara Bio

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer

HIV-AIDS is a chronic disease caused by the human immunodeficiency virus (HIV). HIV virus damages human immune system, which results weakness of immune system and loss ability to fight with organism that causes disease.
HIV-AIDS most often spread through unprotected sex with HIV infected person. In addition, HIV-AIDS can also be spread from infected mother to child during pregnancy, infected blood and sharing needles with someone who has HIV-AIDS. Some of the symptoms of HIV include slight fever, swollen glands, muscle aches, headaches and fatigue.
HIV-AIDS has no cure but there are treatments which help to reduce AIDS deaths. HIV-AIDS can be treated by nucleoside/ nucleotide reverse transcriptase inhibitor, integrase inhibitor, HIV-1 protease inhibitor, non-nucleoside reverse transcriptase inhibitor, pharmacokinetic enhancer and entry inhibitor. Some of the drugs for HIV -AIDS treatment include atripla, epzicom, prezista, truvada, kaletra, isentress, reyataz and viread.
In 2018, the global HIV/AIDS Testing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global HIV/AIDS Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the HIV/AIDS Testing development in United States, Europe and China.

The key players covered in this study
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Lonza
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio

Market segment by Type, the product can be split into
Kits and Reagents
Instruments
Others

Market segment by Application, split into
Hospitals
Private Diagnostics Laboratories
Academic and Research Institutes
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global HIV/AIDS Testing status, future forecast, growth opportunity, key market and key players.
To present the HIV/AIDS Testing development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of HIV/AIDS Testing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.